Position paper nuclear cardiology: Update 2008 - State-of-the-art of scintigraphic methods;Positionspapier nuklear - Kardiologie: Update 2008 aktueller stand der szintigraphischen methodik

NuklearMedizin

Volumn 48, Issue 2, 2009, Pages 71-78

  Schäfers, Michael ^a   Bengel, F ^b   Bull U ^c   Burchert, W ^d   Kies, P ^a   Kluge, R ^e   Krause, B J ^g   Lindner, O ^d   Nienaber, C ^f   Nowak, B ^c   Schafer W ^c   Schober, O ^a   Schwaiger, M ^g   Silber, S ^h   Stegger, L ^a   Vom Dahl, J ⁱ   Zimmermann, R ^j  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e Klinik und Poliklinik für Nuklearmedizin   (Germany)

^f UNIVERSITY OF ROSTOCK   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h Kardiologische Gemeinschaftspraxis und Praxisklinik in der Klinik Dr Müller   (Germany)

ⁱ KLINIKEN MARIA HILF GMBH   (Germany)

^j Klinikum Pforzheim GmbH   (Germany)

more..

Author keywords

Myocardial scintigraphy; Nuclear cardiology; PET; Position paper; SPECT

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE C 11; ACETIC ACID C 11; ACIPIMOX; ADENOSINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMMONIA N 13; DIPYRIDAMOLE; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; HYDROXYEPHEDRINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; RUBIDIUM 82; TETROFOSMIN TC 99M; THALLIUM 201; UNCLASSIFIED DRUG; WATER O 15; DIAGNOSTIC AGENT; THALLIUM;

CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; GERMANY; HEALTH CARE COST; HEART SCINTISCANNING; HUMAN; MEDICAL SOCIETY; NUCLEAR MEDICINE; PHYSICIAN ATTITUDE; POLICY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTIANGIOCARDIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; HEART DISEASE; METHODOLOGY; RADIOGRAPHY;

COST-BENEFIT ANALYSIS; HEART DISEASES; HUMANS; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MEDICINE; RADIOPHARMACEUTICALS; SOCIETIES, MEDICAL; THALLIUM RADIOISOTOPES;

EID: 66449128483     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0220     Document Type: Review

References (63)

1. Schäfers M. Methoden und klinische Anwendung der Nuklearkardiologie: Positionsbericht. Nuklearmedizin 2002; 41: 3-13. (Pubitemid 34193389)
2. Zimmermann R, vom Dahl J, Schäfers M, Schwaiger M. Positionsbericht Nuklearkardiologie. Update. Z Kardiol 2002; 91: 88-92.
3. Schwaiger M. Indikationen für die klinischen anwendung der Positronen-Emissions-Tomographie in der Kardiologie. Positionsbericht der Arbeitsgruppe PET-Kardiologie der Deutschen Gesellschaft für Nuklearmedizin und des Arbeitskreis Nuklearkardiologie der Deutschen Gesellschaft für Kardiologie. Z Kardiol 1996; 85: 453-468.
4. Hesse B, Tagil K, Cuocolo A, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 2005; 32: 855-897. (Pubitemid 41125431)
5. Hesse B, Lindhardt TB, Acampa W et al. EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging 2008; 35: 851-885.
6. Wittry MD, Juni JE, Royal HD et al. Procedure guideline for equilibrium radionuclide ventriculography. society of nuclear medicine. J Nucl Med 1997; 38: 1658-1661.
7. Klocke FJ, Baird MG, Lorell BH et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: A report of the american college of Cardiology/American heart association task force on practice guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). J Am Coll Cardiol 2003; 42: 1318-1333.
8. Tilkemeier PL. ASNC Imaging Guidlines for Nuclear Cardiology Procedures: Standardized reporting of myocardial perfusion images. J Nucl Cardiol 2009; im Druck.
9. Hansen CL, Goldstein RA, Akinoboboye OO et al. ASCN Imaging Guidelines for Nuclear Cardiology. Myocardial Perfusion and Function: Single photon emission computed tomography. J Nucl Cardiol 2007; 14: e39-e60
10. Hendel RC. Attenuation correction: Eternal dilemma or real improvement? Q J Nucl Med Mol Imaging 2005; 49: 30-42.
11. Bateman TM, Berman DS, Heller GV et al. American society of nuclear cardiology position statement on electrocardiographic gating of myocardial perfusion SPECT scintigrams. J Nucl Cardiol 1999; 6: 470-471. (Pubitemid 29405970)
12. Buell U, Schwaiger M. Herz, Kreislauf, Gefäße. In: Buell U, Schicha H, Biersack HJ et al. (eds). Nuklearmedizin. Stuttgart: Georg Thieme 1999: 208-283.
13. Hoer G, Krause BJ, Tillmanns HH. Kardiologische Nuklearmedizin. Landsberg: Ecomed 1997.
14. Mead WF. Maximal exercise testing - bruce protocol. J Fam Pract 1979; 9: 479-490.
15. Gaul G. Stress testing in persons above the age of 65 years: Applicability and diagnostic value of a standardized maximal symptom-limited testing protocol. Eur Heart J 1984; 5 (Suppl E): 51-53. (Pubitemid 15197108)
16. Myers J, Froelicher VF. Exercise testing. procedures and implementation. Cardiol Clin 1993; 11: 199-213.
17. Lear SA, Brozic A, Myers JN, Ignaszewski A. Exercise stress testing. an overview of current guidelines. Sports Med 1999; 27: 285-312. (Pubitemid 29267906)
18. Lollgen H, Ulmer HV, Crean P. Recommendations and standard guidelines for exercise testing. report of the task force conference on ergometry, titisee 1987. Eur Heart J 1988; 9 (Suppl K): 3-37.
19. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: Analysis of 461 patients. J Am Coll Cardiol 1989; 14: 1477-1486. (Pubitemid 19279047)
20. Lette J, Tatum JL, Fraser S et al. Safety of dipyridamole testing in 73,806 patients: The multicenter dipyridamole safety study. J Nucl Cardiol 1995; 2: 3-17.
21. Cerqueira MD, Verani MS, Schwaiger M et al. Safety profile of adenosine stress perfusion imaging: Results from the adenoscan multicenter trial registry. J Am Coll Cardiol 1994; 23: 384-389. (Pubitemid 24049369)
22. Steele P, Sklar J, Kirch D et al. Thallium-201 myocardial imaging during maximal and submaximal exercise: Comparison of submaximal exercise with propranolol. Am Heart J 1983; 106: 1353-1357. (Pubitemid 14214214)
23. Hockings B, Saltissi S, Croft DN, Webb-Peploe MM. Effect of beta adrenergic blockade on thallium-201 myocardial perfusion imaging. Br Heart J 1983; 49: 83-89.
24. Martin GJ, Henkin RE, Scanlon PJ. Beta blockers and the sensitivity of the thallium treadmill test. Chest 1987; 92: 486-487. (Pubitemid 18006610)
25. Zacca NM, Verani MS, Chahine RA, Miller RR. Effect of nifedipine on exercise-induced left ventricular dysfunction and myocardial hypoperfusion in stable angina. Am J Cardiol 1982; 50: 689-695.
26. Aoki M, Sakai K, Koyanagi S et al. Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography. Am Heart J 1991; 121: 1361-1366.
27. Esquivel L, Pollock SG, Beller GA et al. Effect of the degree of effort on the sensitivity of the exercise thallium-201 stress test in symptomatic coronary artery disease. Am J Cardiol 1989; 63: 160-165. (Pubitemid 19032799)
28. Altehoefer C, vom Dahl J, Bares R et al. Metabolic mismatch of septal beta-oxidation and glucose utilization in left bundle branch block assessed with PET. J Nucl Med 1995; 36: 2056-2059.
29. Burns RJ, Galligan L, Wright LM et al. Improved specificity of myocardial thallium-201 single-photon emission computed tomography in patients with left bundle branch block by dipyridamole. Am J Cardiol 1991; 68: 504-508.
30. Rockett JF, Wood WC, Moinuddin M et al. Intravenous dipyridamole thallium-201 SPECT imaging in patients with left bundle branch block. Clin Nucl Med 1990; 15: 401-407. (Pubitemid 20318289)
31. O'Keefe JH Jr, Bateman TM, Silvestri R, Barnhart C. Safety and diagnostic accuracy of adenosine thallium-201 scintigraphy in patients unable to exercise and those with left bundle branch block. Am Heart J 1992; 124: 614-621.
32. Zanco P, Desideri A, Mobilia G et al. Effects of left bundle branch block on myocardial FDG PET in patients without significant coronary artery stenoses. J Nucl Med 2000; 41: 973-977. (Pubitemid 30396643)
33. Maddahi J, Berman DS. Reverse redistribution of thallium-201. J Nucl Med 1995; 36: 1019-1021.
34. Soufer R, Dey HM, Lawson AJ et al. Relationship between reverse redistribution on planar thallium scintigraphy and regional myocardial viability: A correlative PET study. J Nucl Med 1995; 36: 180-187.
35. 18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation 1995; 91: 2435-2444.
36. Knuuti MJ, Nuutila P, Ruotsalainen U et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992; 33: 1255-1262.
37. Bax JJ, Veening MA, Visser FC et al. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Eur J Nucl Med 1997; 24: 35-41. (Pubitemid 27122439)
38. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. generalizations. J Cereb Blood Flow Metab 1985; 5: 584-590. (Pubitemid 16218234)
39. Gambhir SS, Schwaiger M, Huang SC et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med 1989; 30: 359-366. (Pubitemid 19077326)
40. Ohtake T, Kosaka N, Watanabe T et al. Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs. J Nucl Med 1991; 32: 1432-1438.
41. Merlet P, Valette H, Dubois-Rande JL et al. Iodine 123-labeled metaiodobenzylguanidine imaging in heart disease. J Nucl Cardiol 1994; 1: S79-85.
42. Schäfers M, Schober O, Lerch H. Cardiac sympathetic neurotransmission scintigraphy. Eur J Nucl Med 1998; 25: 435-441. (Pubitemid 28211609)
43. Clausen M et al. Arbeitsgemeinschaft Standardisierung. Allgemeine empfehlungen zur standardisierten bilddokumentation. Nuklearmedizin 1997; 36: 53-54.
44. Standardization of cardiac tomographic imaging. the cardiovascular imaging committee, american college of cardiology; the committee on advanced cardiac imaging and technology, council on clinical cardiology, american heart association; and board of directors, cardiovascular council, society of nuclear medicine. J Am Coll Cardiol 1992; 20: 255-256.
45. Cerqueira MD, Weissman NJ, Dilsizian V et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the american heart association. Int J Cardiovasc Imaging 2002; 18: 539-542. (Pubitemid 34262671)
46. Leslie WD, Tully SA, Yogendran MS et al. Prognostic value of automated quantification of 99mTc-sestamibi myocardial perfusion imaging. J Nucl Med 2005; 46: 204-211. (Pubitemid 43073425)
47. DePuey EG, Nichols K, Dobrinsky C. Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT. J Nucl Med 1993; 34: 1871-1876. (Pubitemid 23331250)
48. 99mTc-labeled sestamibi imaging. J Nucl Cardiol 1998; 5: 574-578.
49. Biedenstein S, Schafers M, Stegger L et al. Three-dimensional contour detection of left ventricular myocardium using elastic surfaces. Eur J Nucl Med 1999; 26: 201-207. (Pubitemid 29139848)
50. Imaging guidelines for nuclear cardiology procedures, part 2. american society of nuclear cardiology. J Nucl Cardiol 1999; 6: G47-G84.
51. Hendel RC, Wackers FJ, Berman DS et al. American society of nuclear cardiology consensus statement: Reporting of radionuclide myocardial perfusion imaging studies. J Nucl Cardiol 2003; 10: 705-708. (Pubitemid 38035409)
52. ICRP publication 62. radiological protection in biomedical research. Annals of the IRCP Vol. 22/4, Pregamon Press 1993.
53. ICRP publication 80. radiation dose to patients from radioparmaceuticals. Annals of the IRCP Vol. 28/3, Pregamon Press 1998.
54. Johansson L. Hormesis, an update of the present position. Eur J Nucl Med Mol Imaging 2003; 30: 921-933.
55. Feinendegen LE. Evidence for beneficial low level radiation effects and radiation hormesis. Br J Radiol 2005; 78: 3-7. (Pubitemid 40277127)
56. Bundesamt für Strahlenschutz
57. Kranert WT, Hör G. Strahlenexposition bei herzuntersuchungen. In: Hör G, Krause BJ, Tillmann HH (Hrsg). Kardiologische Nuklearmedizin. Landsberg: Ecomed 1997.
58. Schober O, Lottes G. Positron emission tomography and radiation exposure. Nuklearmedizin 1994; 33: 174-177. (Pubitemid 24320016)
59. Des Prez RD, Shaw LJ, Gillespie RL et al. Cost-effectiveness of myocardial perfusion imaging: A summary of the currently available literature. J Nucl Cardiol 2005; 12: 750-759. (Pubitemid 43033615)
60. Shaw LJ, Hachamovitch R, Heller GV et al. Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. the economics of noninvasive diagnosis (END) study group. Am J Cardiol 2000; 86: 1-7.
61. Giri S, Shaw LJ, Murthy DR et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002; 105: 32-40. (Pubitemid 34049139)
62. Shaw LJ, Hachamovitch R, Berman DS et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: An observational assessment of the value of precatheterization ischemia. economics of noninvasive diagnosis (END) multicenter study group. J Am Coll Cardiol 1999; 33: 661-669.
63. Underwood SR, Godman B, Salyani S et al. Economics of myocardial perfusion imaging in europe - the EMPIRE study. Eur Heart J 1999; 20: 157-166. (Pubitemid 29048087)